thank you, mark, and good morning to everyone?
compname reports q4 net income of $2.9 billion.
sees q2 adjusted non-gaap earnings per share $0.22.
q4 medical care net sales $23.1 million versus refinitiv ibes estimate of $22.4 million.
q2 operating revenue rose nearly 5 percent to $63 billion.
q1 operating margin increased in full-year 2021.
compname reports fy sales rose 8.3%.
qtrly total health care medical benefit ratio of 81.8%.
compname reports q3 adjusted operating expense ratio of 18.1%, an 80 basis point improvement from year-ago quarter.
compname reports q4 revenue $15.7 bln versus refinitiv ibes estimate of $15 billion.
compname reports q4 adjusted operating margin of 6.4%.
compname says had fiscal 2022 medical expense ratio of 85.1%.
compname reports q4 adjusted operating expense ratio 19.8% compared to 19.1% in q4 of 2021.
quarterly earnings per share view increases.
q3 earnings per share $1.49.
compname reports q3 earnings of $2 per share, up 54% versus prior year quarter.
